Trials / Unknown
UnknownNCT05667350
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary Tract Cancer (ASCEND-BTC)
Exploration and Validation of a Diagnosis Model for Biliary Tract Cancer Based on Combined Liquid Biopsy in Peripheral Blood: A Multi-center Prospective Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 492 (estimated)
- Sponsor
- Eastern Hepatobiliary Surgery Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
ASCEND-BTC is a prospective, multi-center, observational study aimed at detecting early biliary tract cancer by combined assays of serum protein and cell-free DNA (cfDNA) methylation. The study will enroll approximately 492 participants diagnosed with biliary tract cancer and benign diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood drawing | Blood drawing before anti-cancer therapy |
| OTHER | Blood drawing | Blood drawing before radical treatment |
Timeline
- Start date
- 2022-02-28
- Primary completion
- 2023-12-31
- Completion
- 2024-06-30
- First posted
- 2022-12-28
- Last updated
- 2022-12-30
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05667350. Inclusion in this directory is not an endorsement.